Article Versions Notes

Liu Q, Tan J, Zhao Z, Li R, Zheng L, Chen X, Li L, Dong X, Wen T, Liu J. Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line. Biomedicines. 2023; 11(1):8. https://doi.org/10.3390/biomedicines11010008

Liu, Qun, Jingyu Tan, Zhenguo Zhao, Ruijun Li, Luyu Zheng, Xiangyu Chen, Lina Li, Xichen Dong, Tao Wen, and Jian Liu. 2023. "Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line" Biomedicines 11, no. 1: 8. https://doi.org/10.3390/biomedicines11010008

Liu, Q., Tan, J., Zhao, Z., Li, R., Zheng, L., Chen, X., Li, L., Dong, X., Wen, T., & Liu, J. (2023). Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line. Biomedicines, 11(1), 8. https://doi.org/10.3390/biomedicines11010008